Show You Know: Assess Patients for Appropriate COVID-19 Therapeutics

Assess Patients for Appropriate COVID-19 Therapeutics

Pharmacists have been pivotal in the fight against COVID-19. Under the PREP Act, pharmacy technicians, pharmacy interns, and pharmacists have been immunizing community members and dispensing COVID-19 therapeutics. Most recently, pharmacists have been given the authority to prescribe one COVID-19 oral therapeutic.
Test your knowledge with this short quiz.
Supported by Pfizer. Pfizer%20Logo.jpg

PATIENT PROFILE:

Name: BW	Sex: Female	Age: 54 years	Race: White
Height: 5'6"	Weight:180 lb	Blood Pressure: 115/77 mm Hg
Current Medications: Lisinopril 20 mg daily		Medical Conditions: Substance use disorder Former smoker Hypertension	Allergies: NKDA
Complete Blood Count: WBC -> 5.5 x 10³/μL RBC -> 5.247 x 10³/μL Hemoglobin -> 15.4 g/dL Hematocrit -> 44.1% Platelets -> 268 x 10³/μL		Comprehensive Metabolic Panel: Na -> 138 mEq/L K -> 4.2 mEq/L Cl -> 108 mEq/L HCO_3- -> 22 mEq/L Glucose -> 95 mg/dL SCr -> 1.4 mg/dL BUN -> 14 mg/dL Albumin -> 3.6 g/L ALP -> 103 units/L ALT -> 24 U/L AST -> 10 U/L Bilirubin -> 0.4 mg/dL	Lipid Panel: Cholesterol, Total -> 180 mg/dL HDL -> 62 mg/dL Triglycerides -> 60 mg/dL LDL -> 106 mg/dL Other: TSH -> 1.2 mU/L T4 -> 7 μg/dL T3 -> 100 ng/dL Vitamin D -> 38.2 ng/mL

Q1: BW, a 54-year-old female, calls the pharmacy with a positive COVID-19 test and emails her lab results from 2 months ago. She has loss of taste, fatigue, and sore throat since yesterday. Her SpO2 is 95%. Which is the appropriate course of action?*

a. Prescribe and dispense nirmatrelvir/ritonavir 300/100 mg twice daily for 5 days.

b. Prescribe and dispense nirmatrelvir/ritonavir 150/100 mg twice daily for 5 days.

c. Refer patient to emergency department for possible remdesivir administration because there are irreconcilable drug-drug interactions.

d. Patient does not meet the criteria for treatment with oral antiviral.

1
Q1
2
Q2
3
Q3
4
Q4
5
Q5
6
Final Results

Share

Assess Patients for Appropriate COVID-19 Therapeutics

Q1: BW, a 54-year-old female, calls the pharmacy with a positive COVID-19 test and emails her lab results from 2 months ago. She has loss of taste, fatigue, and sore throat since yesterday. Her SpO2 is 95%. Which is the appropriate course of action?*